Legend Biotech LEGN Stock
Legend Biotech Price Chart
Legend Biotech LEGN Financial and Trading Overview
| Legend Biotech stock price | 34.28 USD |
| Previous Close | 68.97 USD |
| Open | 68.34 USD |
| Bid | 70.02 USD x 1000 |
| Ask | 73.86 USD x 900 |
| Day's Range | 68.21 - 72.21 USD |
| 52 Week Range | 37.3 - 73.3 USD |
| Volume | 1.03M USD |
| Avg. Volume | 880.92K USD |
| Market Cap | 12.85B USD |
| Beta (5Y Monthly) | -0.051387 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.96 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 82.5 USD |
LEGN Valuation Measures
| Enterprise Value | 10.86B USD |
| Trailing P/E | N/A |
| Forward P/E | -25.537634 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 124.39385 |
| Price/Book (mrq) | 18.024284 |
| Enterprise Value/Revenue | 105.147 |
| Enterprise Value/EBITDA | -21.408 |
Trading Information
Legend Biotech Stock Price History
| Beta (5Y Monthly) | -0.051387 |
| 52-Week Change | 60.54% |
| S&P500 52-Week Change | 19.24% |
| 52 Week High | 73.3 USD |
| 52 Week Low | 37.3 USD |
| 50-Day Moving Average | 64.27 USD |
| 200-Day Moving Average | 51.84 USD |
LEGN Share Statistics
| Avg. Volume (3 month) | 880.92K USD |
| Avg. Daily Volume (10-Days) | 968.14K USD |
| Shares Outstanding | 180.35M |
| Float | 71.38M |
| Short Ratio | 7.19 |
| % Held by Insiders | 1.41% |
| % Held by Institutions | 39.26% |
| Shares Short | 4.53M |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 2.51% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -500.39% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.71% |
| Return on Equity (ttm) | -96.39% |
Income Statement
| Revenue (ttm) | 103.3M USD |
| Revenue Per Share (ttm) | 0.64 USD |
| Quarterly Revenue Growth (yoy) | -12.099% |
| Gross Profit (ttm) | -284006000 USD |
| EBITDA | -507374752 USD |
| Net Income Avi to Common (ttm) | -526160992 USD |
| Diluted EPS (ttm) | -3.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 850.12M USD |
| Total Cash Per Share (mrq) | 5.14 USD |
| Total Debt (mrq) | 314.76M USD |
| Total Debt/Equity (mrq) | 48.19 USD |
| Current Ratio (mrq) | 3.843 |
| Book Value Per Share (mrq) | 3.953 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -263647008 USD |
| Levered Free Cash Flow (ttm) | -286797632 USD |
Profile of Legend Biotech
| Country | United States |
| State | NJ |
| City | Somerset |
| Address | 2101 Cottontail Lane |
| ZIP | 08873 |
| Phone | 732 317 5050 |
| Website | https://www.legendbiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1390 |
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia , gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.
Q&A For Legend Biotech Stock
What is a current LEGN stock price?
Legend Biotech LEGN stock price today per share is 34.28 USD.
How to purchase Legend Biotech stock?
You can buy LEGN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Legend Biotech?
The stock symbol or ticker of Legend Biotech is LEGN.
Which industry does the Legend Biotech company belong to?
The Legend Biotech industry is Biotechnology.
How many shares does Legend Biotech have in circulation?
The max supply of Legend Biotech shares is 183.65M.
What is Legend Biotech Price to Earnings Ratio (PE Ratio)?
Legend Biotech PE Ratio is now.
What was Legend Biotech earnings per share over the trailing 12 months (TTM)?
Legend Biotech EPS is -0.96 USD over the trailing 12 months.
Which sector does the Legend Biotech company belong to?
The Legend Biotech sector is Healthcare.
Legend Biotech LEGN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4148.65 USD — |
+0.54
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8504.39 USD — |
+1.34
|
— — | 8367.19 USD — | 8515.13 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4131.38 USD — |
-1.41
|
— — | 4109.33 USD — | 4165.2 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}